RecruitingNot ApplicableNCT07625969

Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students


Sponsor

Nanjing Medical University

Enrollment

1,000 participants

Start Date

Jul 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called choice architecture, a behavioral approach called choice architecture, and others for people with food selection and obesity. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALchoice architecture

Showing the various harms that can come from long-term excessive consumption of sugary beverages on the platform.

BEHAVIORALchoice architecture

The platform shows the hedonic information about sugar-free beverages.

BEHAVIORALchoice architecture

The platform shows both hedonic information about sugar-free beverages and information on the various harms of long-term excessive sugary beverage consumption.


Locations(1)

Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07625969


Related Trials